CLASS II Drug recall · Reported 21 Dec 2016 · FDA Enforcement Report
Oxytocin 30 USP Units Added to 0.9% Sodium Chloride recalled
Cantrell Drug is recalling Oxytocin 30 USP Units Added to 0.9% Sodium Chloride, Single-Dose, Injection Solution for, distributed nationwide in the US. The recall was initiated on 18 Nov 2016 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0201-2017
- FDA event ID
- 75745
- Recalling firm
- Cantrell Drug, Little Rock, AR
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 18 Nov 2016
- FDA classified
- 13 Dec 2016
- Reported
- 21 Dec 2016
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 18 Nov 2016 | Recall initiated by company | |
| 13 Dec 2016 | Classified by FDA | +25 days |
| 21 Dec 2016 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Oxytocin 30 USP Units Added to 0.9% Sodium Chloride, 500 mL Bag, Single-Dose Bag, Injection Solution for IV Use Only, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-056-30
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Which lots are affected?
Lot: 9210
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
20 other products · FDA event 75745This product is part of a recall event; the main page for the event is Lidocaine HCl 1% Syringe, Hospital/Office Use Only recalled.
More recalls from Cantrell Drug
All 52| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ephedrine Sulfate in 0.9% Sodium Chloride, 50 mg recalled | Cantrell Drug | Sterility | Nationwide |
| Drug | CLASS II | Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium recalled | Cantrell Drug | Sterility | Nationwide |
| Drug | CLASS II | Diltiazem HCl 125 mg in 5% Dextrose Single-Dose recalled | Cantrell Drug | Sterility | Nationwide |
| Drug | CLASS II | Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium recalled | Cantrell Drug | Sterility | Nationwide |
| Drug | CLASS II | Adenosine in 0.9% Sodium Chloride, 90 mg recalled by Cantrell Drug | Cantrell Drug | Sterility | Nationwide |